Help others to be mothers - please sign and share the Progress Educational Trust's petition, calling on the UK Government to #ExtendTheLimit on social egg freezing
Page URL:

Genetic test speeds up diagnosis for children with cataracts

16 September 2013
Appeared in BioNews 722

A blood test for children born with cataracts will allow faster diagnosis and more personalised treatment, according to researchers at the British Society for Genetic Medicine's annual conference.

The team, from the Centre for Genomic Medicine at the University of Manchester, have developed a test that checks all genes known to cause congenital cataracts using just one blood sample.

'Using next-generation sequencing, we are now able to identify the cause of cataracts in children in a way that is much faster and more cost-effective than the current method', says Rachel Gillespie, who developed the test.

Congenital cataracts are a leading cause of blindness in children, affecting around 200,000 children around the world every year. It is thought that around half of cases are due to genetic mutations, while the remainder are caused by environmental risk factors during pregnancy - for example, exposure to infections such as rubella.

Mutations in more than 100 genes have been linked to congenital cataracts. Conventional screening methods involve the consecutive testing of each gene separately to determine the precise genetic cause, which is a time-consuming and costly process.

'At the moment, screening for one gene takes around four weeks. There are more than 100 known genes linked to congenital cataracts, so establishing the cause by screening genes individually can sometimes take years', says Gillespie. 'Our test looks at all of these genes in parallel, so patients can be diagnosed much faster and receive the treatment, clinical management and genetic counselling they need'.

As more patients are tested and more knowledge is gained about the genetic basis of the condition, it is hoped that pinpointing the exact mutation responsible will enable doctors to make more accurate predictions, regarding how the cataracts may progress and what the outcome of surgery may be.

Genetic testing can also bring to light more complex conditions, whose symptoms typically do not emerge until later in life. 'In some cases, we have identified that the cataracts aren't just a standalone problem, but a symptom of a more complex syndrome', says Gillespie. 'This includes Warburg micro syndrome and galactokinase deficiency, both rare conditions that are probably under-diagnosed, as warning signs in children can be subtle'.

Rachel Gillespie was talking about her work prior to her presentation 'Next generation sequencing as a powerful means of diagnosis for congenital cataract' at the British Society for Genetic Medicine's annual conference, held at the Liverpool Arena and Convention Centre on Monday 16 September 2013.

14 March 2016 - by Kulraj Singh Bhangra 
Scientists have shown that stem cells found in the eye can restore vision in children with cataracts...
18 February 2013 - by Maria Sheppard 
Twenty-four genes linked to short-sightedness have been identified by an international consortium of scientists...
28 May 2012 - by Ana Pallesen 
Two patients with corneal blindness have become the first people in the UK to have stem cells transplanted into their eyes in order to restore their sight...
31 August 2010 - by Sarah Pritchard 
Researchers have discovered that people who carry a mutated form of the transcription factor 4 gene (TCF4) have as much as a 30-fold increased risk of developing Fuchs's corneal dystrophy...
1 May 2009 - by Dr Nadeem Shaikh 
Three people suffering from blindness in one eye have been given a new medical treatment to radically improve their eyesight by a team working at the Australian University of New South Wales. According to the journal Transplantation, the method involves taking 'limbal' stem cells from the patient's...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.